Securitize Corp. enters the final days of September with its lending market pulling back from extremes while short positioning stays stubbornly elevated, a split that leaves the stock trading at $15.84 after a 22% weekly gain and a 5% Friday reversal.
The borrow story has changed materially since last week's notes. Cost to borrow peaked at 133% on September 21. It closed Tuesday at 36.8%, less than a third of that peak. Availability has also recovered, rising to 20.7% from 0.06% ten days ago, meaning roughly one share is now available to borrow for every five already lent out. That remains tight by any historical standard, and the 52-week minimum availability was 0.06%, so the pool has clearly refilled. But the acute squeeze pressure that defined mid-September has eased. What has not eased is the short position itself. Estimated shares short climbed 98% over the past week to 9.4 million, almost exactly where they were on September 25 before a one-day pullback. The lending market is normalising; the bears are not retreating. Options add nuance. The put/call ratio is running at 0.35, nearly 1.9 standard deviations above its 20-day average of 0.20. That is a meaningful shift in a stock that spent most of August and early September with a PCR below 0.17. Calls still dominate, but the balance has tilted toward more defensive positioning over the past ten days, consistent with investors hedging a position after a 152% one-month rally.
The Street remains constructive but is now trailing the price. Analysts have been active: Cantor Fitzgerald initiated at Overweight with a $21.20 target on September 21, the most bullish call in the coverage universe. Rosenblatt lifted to $13 the same day. StoneX raised to $12 from $10 three days earlier. The result is a consensus of Buy-equivalent ratings across all covering analysts, with a mean target of around $13.94. Against a $15.84 close, that implies meaningful downside to consensus, a reversal from two weeks ago when the stock was trading below most targets. The bull case centres on Securitize's position in real-world asset tokenization, the potential scale of that market, and regulatory tailwinds from the CLARITY Act. The bear case is sharper now than it was: revenue dependence on a small number of platform integration relationships, financial results that have yet to demonstrate consistent profitability, and a stock that has run well past where the Street's models currently sit.
The ownership register adds an important layer. Both Blockchain Capital and CEO Carlos Domingo filed Schedule 13D disclosures in early July, meaning both are on the register as activists around the 5% threshold. Blockchain Capital last disclosed a 6.0% stake of approximately 9.8 million shares; Domingo disclosed 5.4% at around 9.0 million shares. These are event-driven disclosures and stakes are as last disclosed, holders dropping below 5% may not file again. The September 10 Form 4 filings show the CEO, CFO, and COO all received share awards, transaction code "A" grants rather than open-market purchases, so these carry limited sentiment signal on their own. The ORTEX short score has ticked up to 74.6, the highest reading in the available history, reinforcing that positioning pressure on the short side remains near its recent peak even as the mechanical squeeze conditions have loosened.
Earnings history here is notable for its volatility. The September 4 print produced a 16% one-day gain and held most of it over five days. The August 13 print produced a 29% one-day drop and gave back roughly 19% over five days. The next event is scheduled for November 12. With the stock having moved 152% in a month and now sitting above where most analysts have their targets, the gap between market price and fundamental valuation will likely be the central question heading into that print.
What to watch next: whether short interest continues to climb toward the 10 million share level last seen on September 25, whether borrow availability tightens again if that happens, and whether any analyst revises their target above the current $15.84 price to restore a positive return-to-target.
See the live data behind this article on ORTEX.
Open SECZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
